An observational study in Benign Prostatic Hyperplasia, Micturition Disorder and Urinary Obstruction, sponsored by Ankara City Hospital Bilkent. Completed at 1 site in Turkey. Open to male participants aged 45 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-02-15.
Sponsored by Ankara City Hospital Bilkent · Observational
There are many factors that affect uroflowmetry parameters. One of these is the urination position. Research has mostly focused on standing and sitting urination positions. However, those who prefer the standing position as a habit can urinate by opening the zipper or lowering the trousers. Although the effect of these two applications on uroflowmetry parameters in healthy men has been investigated in only one study, their effect on patients with lower urinary tract symptoms has not been examined.
783 studies on the registry are indexed under Prostatic Hyperplasia; 174 are open to participants now.
This study's enrollment of 80 is below the median of 214 across 167 observational studies indexed under Prostatic Hyperplasia.
Browse Prostatic Hyperplasia studies →Ankara City Hospital Bilkent is the lead sponsor of 424 studies on the registry; 105 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients on alpha blocker therapy with LUTS due to BPO
Exclusion Criteria:
Diagnostic Test: position of urination
Diagnostic Test: position of urination
effect of position on uroflowmetry parameters
Qmax
Time frame: During the procedure
PVR
Time frame: Immediately after procedure
Qave
Time frame: During the procedure
Duration of voiding
Time frame: During the procedure
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ankara City Hospital Bilkent